Christie's Auction House, it turns out, had a rat.

Christopher Davidge, the CEO of the art auction house, took the only path he saw that would keep him out of jail. He went to the authorities.

At issue was a price-fixing scheme – a cartel – that had lasted for seven years and funneled untold millions from the pockets of rich art collectors to the accounts of the wealthy auction houses.

For decades, competition between Christie's and rival Sotheby's had been fierce, each vying for the best artwork to bolster its auctions and collect the most fees.

In 1993, Davidge and Sotheby's CEO Diana Brooks – along with the chairmen of the two companies, Anthony Tennant and A. Alfred Taubman – were tired of competing.

Instead, they held secret meetings to establish fixed fees.

When a customer sold a piece of art through the auction house, they'd pay a fee. And like anyone else, they preferred to pay as little as possible.

Instead of engaging in an endless price war, Christie's and Sotheby's formed a cartel to agree on an artificially elevated price. The scheme worked for seven years.

But it eventually broke down, as most cartels do. Not only is it illegal, but it's hard to keep up a price-fixing scheme. If the industry agrees to a set price, one participant can attract extra business and make a lot of extra money by just lowering its price a small amount. And before long, one of the cartel members will give in to temptation.

Or sometimes the scheme can attract the scrutiny of regulators... That's what happened to Christie's. Davidge was leaving the firm, and he decided he didn't want to carry the risk and guilt with him to his next job. The chairmen, Tennant and Taubman, had kept good records of their illegal activities – the best criminals do.

Davidge dumped it all into the lap of investigators in exchange for leniency. The businesses paid out half a billion dollars in civil settlements. Taubman and Brooks went to jail. And you can see what the scandal did to the companies' shares...

Despite the risks (and questionable ethics)... you can see the appeal of trying to set your prices. Most of the time, businesses must compete on quality and price. And except for a few businesses with strong brands or no competition, companies take what the market gives them.

This leads to a cyclical flow of high and low prices. When you can spot these cycles, they make for outstanding trades. If you can buy when supply is tight and prices are high, you position yourself to win.

There are a handful of industries that follow regular, recurring cycles of this competition.

The airline industry has traditionally been one of them. When the economy gets hot, people start traveling more and paying more for tickets. The airlines start chasing more dollars and expanding the number of flights they offer. Then, prices come crashing down.

Another cyclical industry is oil. When oil supplies are low, prices are high... And producers plow money into exploring and drilling. That process increases production and drives oil prices down. Everyone goes bust. The drilling party stops. Eventually, though, that lack of drilling leads to lower supply... And prices rise.

These businesses would love to find ways to smooth out these cycles. Oil, for one, has established an international pricing cartel known as OPEC. The managers of airlines have likewise promised investors that they'll be "disciplined" with their expansions, and they have been so far.

By understanding these cyclical moves, you can avoid getting the timing wrong on your investments...

And my team and I have created a way to help you. With my StockTracker system, you can get an inside line on what stocks and sectors will be the hottest over the next month, three months, and up to a year.

You can see what's in favor... what's out of favor... and what's next to outpace the rest of the market with a simple glance.

You can find the stocks that are bottoming... and those that are topping out after a big run... all with a peek at a chart.

It's a way to look at stocks that you've probably never seen before. And for many folks, it doesn't make any sense... at first.

But it can become one of the most intuitive technical indicators you use.

Last week, I went on camera to show how my StockTracker works. If you haven't seen my big reveal yet, make sure to check it out before it goes offline tomorrow.

What We're Reading (and Watching)...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
July 20, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top